Exciting News! Lotus Clinical Research is now powered by ETQ Reliance Quality Management System! We are thrilled to announce that Lotus Clinical Research has joined
News & Press
South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial
South Rampart Pharma Announces First Patient Enrolled in Multiple Ascending Dose Portion of Ongoing Phase 1 Clinical Trial – SRP-001, a novel, non-opioid investigational drug that
We are very excited to introduce Erin Berg as our Director of Project Management at Lotus Clinical Research. In her role, Erin will be leveraging her
Lotus and ERG effectively kick off their inaugural internal CRA Academy! Cassie Witte asks the creator and facilitator of the CRA Academy, Marilyn Greenwalt, and
We are thrilled to introduce Sandra Winsett as the Director of Clinical Systems at Lotus Clinical Research! Sandra brings over 15 years of experience in
Lotus Clinical Research Announces Strategic Partnership with Trialogics For Clinical Trial Software Services
Today, Lotus Clinical Research announced it has entered into a strategic partnership with Trialogics to strengthen their existing relationship and expand Lotus’ use of Trialogics’ clinical trial software offerings.
We are delighted to announce that our Vice President of Clinical Development, Erin Tireman, Psy.D, will now be overseeing medical writing services as an expansion of her current leadership role within Lotus’ Scientific Services division.
Fast-growing CRO utilizes Veeva Vault Clinical Suite to substantially decrease startup time — Veeva Systems (NYSE: VEEV) today announced that Lotus Clinical Research expanded its partnership with Veeva..
Pacira Biosciences Announces Positive Topline Data From Phase 3 Study of Exparel as a Single-Dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in bunionectomy, providing scientific consulting and conducting the study within our CRO and the ERG site network.
Pacira Biosciences Announces Positive Topline Data From Phase 3 Study of Exparel as a Single-Dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
News & Press Lotus Clinical Research worked closely with Pacira on this successful pivotal Phase 3 trial in total knee arthroplasty (TKA), providing scientific consulting
Below please find my comments on FDA’s draft document: Development of Non-Opioid Analgesics for Acute Pain: Guidance for Industry, dated February 7, 2022. I am a board-certified anesthesiologist and Chief Scientific Officer of Lotus Clinical Research, LLC, a contract research organization, regulatory consulting firm and research site network specializing in analgesic clinical trials.
Innocoll Announces Positive Topline Results for XARACOLL® (bupivacaine hydrochloride) Implant in a Phase 3 Study to Support Expanded Use
Lotus Clinical Research worked closely with Innocoll on this successful pivotal Phase 3 trial in abdominoplasty, providing scientific and regulatory consulting and conducting the study within our CRO and the ERG site network.